Etheresia Pretorius

Resia Pretorius (PhD) is a Distinguished Professor at Stellenbosch University (South Africa), Honorary Professor at the University of Liverpool (UK) and a founding director of Biocode Technologies, a Stellenbosch University start-up company. She has advanced the field of coagulation system pathophysiology, by studying the interactions of inflammatory molecules with clotting proteins, platelets, erythrocytes and endothelial cells. Since 2000, she has published and in press, 334 papers, and in collaboration with Stellenbosch University, she has filed various patents related to methods for the early detection of inflammatory disease risk and for the diagnosis of coagulation pathology in Long COVID and inflammatory diseases. She is actively involved in global health initiatives, including the World Health Network (WHN), and serves on the scientific advisory board of Phys2biomed in Italy, and is a scientific advisor of the Long COVID Foundation in Leeds, UK (https://longcovidfdn.com/). She has also been a member of WHO panels in 2021, 2022 and 2024 (ongoing), that aimed to expand the understanding of post-COVID-19 conditions.